Valentini, Vincenzo
 Distribuzione geografica
Continente #
NA - Nord America 16.805
EU - Europa 16.210
AS - Asia 4.072
AF - Africa 162
SA - Sud America 64
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 34
Totale 37.397
Nazione #
US - Stati Uniti d'America 16.615
DE - Germania 5.295
SE - Svezia 3.574
CN - Cina 2.242
IT - Italia 1.863
UA - Ucraina 1.332
IE - Irlanda 1.013
FR - Francia 831
SG - Singapore 700
GB - Regno Unito 507
IN - India 479
FI - Finlandia 398
PL - Polonia 396
RU - Federazione Russa 396
TR - Turchia 250
BE - Belgio 171
CA - Canada 154
CZ - Repubblica Ceca 129
CI - Costa d'Avorio 126
JP - Giappone 86
IR - Iran 83
NL - Olanda 57
HK - Hong Kong 56
AT - Austria 55
AU - Australia 45
CH - Svizzera 43
VN - Vietnam 38
ES - Italia 34
RO - Romania 25
MX - Messico 23
EU - Europa 22
BR - Brasile 21
KR - Corea 19
CL - Cile 18
PE - Perù 18
IL - Israele 16
NO - Norvegia 15
ID - Indonesia 13
PH - Filippine 12
GR - Grecia 11
PT - Portogallo 11
A2 - ???statistics.table.value.countryCode.A2??? 10
RS - Serbia 10
MY - Malesia 9
EG - Egitto 8
SA - Arabia Saudita 8
DK - Danimarca 7
DZ - Algeria 7
PA - Panama 7
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
LK - Sri Lanka 6
MA - Marocco 6
IQ - Iraq 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
BD - Bangladesh 4
BH - Bahrain 4
HU - Ungheria 4
KZ - Kazakistan 4
LT - Lituania 4
LU - Lussemburgo 4
MT - Malta 4
TH - Thailandia 4
TW - Taiwan 4
AM - Armenia 3
BG - Bulgaria 3
BZ - Belize 3
CY - Cipro 3
EC - Ecuador 3
HR - Croazia 3
JO - Giordania 3
KE - Kenya 3
KW - Kuwait 3
A1 - Anonimo 2
AL - Albania 2
AR - Argentina 2
DO - Repubblica Dominicana 2
LV - Lettonia 2
MK - Macedonia 2
MU - Mauritius 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
BY - Bielorussia 1
CM - Camerun 1
CO - Colombia 1
CU - Cuba 1
ET - Etiopia 1
GE - Georgia 1
MN - Mongolia 1
MW - Malawi 1
NG - Nigeria 1
NP - Nepal 1
QA - Qatar 1
UZ - Uzbekistan 1
VA - Santa Sede (Città del Vaticano) 1
VE - Venezuela 1
ZA - Sudafrica 1
ZW - Zimbabwe 1
Totale 37.397
Città #
Chandler 4.030
Ashburn 1.332
Dublin 1.008
Jacksonville 819
San Mateo 757
Ann Arbor 633
New York 527
Nanjing 514
Wilmington 514
Milan 426
Singapore 425
Woodbridge 378
Warsaw 365
Boston 361
Dearborn 354
Princeton 293
Nürnberg 289
Beijing 285
Moscow 280
Fairfield 273
Houston 263
Marseille 263
Rome 262
Bremen 247
Lawrence 244
Cattolica 232
Izmir 218
Redwood City 203
Los Angeles 184
Seattle 181
Nanchang 179
Brussels 168
Zhengzhou 152
Chicago 133
Helsinki 129
Abidjan 126
Boardman 126
Munich 117
Leawood 91
Shenyang 91
Kunming 86
Norwalk 82
Pune 74
Hebei 73
Jiaxing 73
Augusta 71
Cambridge 70
Tianjin 69
Brno 68
Mountain View 67
Detroit 66
University Park 66
Changsha 65
Toronto 65
Washington 65
Fremont 64
Hangzhou 60
Shanghai 58
Vienna 51
Falls Church 47
Redmond 46
Phoenixville 43
North York 42
San Diego 42
Lancaster 41
Andover 40
London 36
Guangzhou 35
Hong Kong 35
Jinan 35
Leesburg 34
Hefei 31
Simi Valley 28
Hanoi 27
Kish 27
Monmouth Junction 27
Auburn Hills 23
Busto Arsizio 23
Ningbo 23
Edinburgh 22
Phoenix 22
Amsterdam 21
Lanzhou 21
Tokyo 21
Kraków 20
Ardabil 19
Cuauhtémoc 19
Frankfurt am Main 19
San Francisco 19
Bologna 18
Indiana 18
San Jose 18
Dresden 17
Ottawa 16
Lima 15
Las Vegas 14
Paris 14
Berlin 13
Chengdu 13
Sacramento 13
Totale 19.822
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 793
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 305
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 250
Neoadjuvant Concurrent Radiochemotherapy in Locally Advanced (IIIa-IIIb) Non-Small Cell Lung Cancer: long term results according to downstaging. 238
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 233
EP-1325 Personalized Medicine in breast cancer: a nomogram from prognostic score to deescalate radiotherapy 220
The role of radiotherapy (RT) in the treatment of Adenoid Cystic Carcinoma of the Breast: case report of RT retreatment and literature review 218
Diffusion-Weighted Magnetic Resonance Imaging in Monitoring Rectal Cancer Response to Neoadjuvant Chemoradiotherapy. 212
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study. 206
Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives. 197
EP-1181: Prostheses irradiation in breast cancer: clinical and aesthetic outcomes in retrospective series 193
Can Elderly Patients With Newly Diagnosed Glioblastoma be Enrolled in Radiochemotherapy Trials? 191
HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? 186
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 173
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 168
Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population 166
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 165
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 164
Medicine is a science of uncertainty and an art of probability (Sir W. Osler) 164
Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092) 161
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 161
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 161
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 158
Adjuvant radiotherapy in non small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. 157
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 156
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 144
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemoterapy and radioation therapy 143
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 142
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 140
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. 137
Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis. 137
 ¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose. 136
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 135
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 134
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 134
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 133
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 132
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. 132
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 131
Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis 131
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 130
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 129
Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators--a pilot study 128
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go 128
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system 127
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 126
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 126
Evidence and research perspectives for surgeons in the European Rectal Cancer Consensus Conference (EURECA-CC2). 125
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 125
Reducing heart dose during left breast cancer radiotherapy: comparison among 3 radiation techniques 125
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 124
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 124
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 123
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 123
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 122
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 122
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 122
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 121
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. 120
Oncological outcome of hypopharyngeal carcinoma treated with different modalities at two different university hospitals 119
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 119
Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy 118
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 117
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 116
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 116
Multiple abscesses in a patient treated with cetuximab 114
The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy 114
International consensus guidelines on Clinical Target Volume delineation in rectal cancer 114
Oncological outcome in advanced laryngeal cancers treated with different modalities in a single institution. A retrospective analysis on 65 cases. 113
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 113
Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study 111
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 109
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 108
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach 108
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 107
Comparison of total laryngectomy with surgical (cricohyoidopexy) and nonsurgical organ-preservation modalities in advanced laryngeal squamous cell carcinomas: A multicenter retrospective analysis 107
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 106
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 105
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 105
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 105
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 105
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 104
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 104
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? 103
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 103
HPV and EBV Infections in Neck Metastases from Occult Primary Squamous Cell Carcinoma: Another Virus-Related Neoplastic Disease in the Head and Neck Region 103
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 102
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 102
Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma 101
Lung abnormalities at multimodality imaging after radiation therapy for non-small cell lung cancer 101
No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT) 101
Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases 100
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 100
Cutaneous squamous cell carcinoma. Italian guidelines by SIDeMaST adapted to and updating EADO/EDF/EORTC guidelines 100
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 99
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 98
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 98
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 98
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 98
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 98
Totale 14.169
Categoria #
all - tutte 163.739
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 163.739


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.113 0 219 191 167 430 424 538 242 574 293 673 362
2020/20213.386 204 380 108 376 504 152 341 79 370 213 546 113
2021/20225.273 515 307 103 409 253 169 80 720 234 350 1.136 997
2022/202311.269 1.575 1.543 876 1.756 672 1.318 568 877 1.256 241 414 173
2023/20245.563 230 1.524 224 369 241 861 324 300 79 191 578 642
2024/2025411 314 97 0 0 0 0 0 0 0 0 0 0
Totale 38.560